175 related articles for article (PubMed ID: 8625052)
1. Proliferating cell nuclear antigen and Ki-67 immunohistochemistry of oligodendrogliomas with special reference to prognosis.
Heegaard S; Sommer HM; Broholm H; Broendstrup O
Cancer; 1995 Nov; 76(10):1809-13. PubMed ID: 8625052
[TBL] [Abstract][Full Text] [Related]
2. Immunocytochemical detection of cell proliferation-related antigens in cytologic smears of human malignant neoplasms using PC10, reactive with proliferating cell nuclear antigen, and Ki-67. A comparative study.
Pelosi G; Bresaola E; Manfrin E; Rodella S; Schiavon I; Iannucci A
Arch Pathol Lab Med; 1994 May; 118(5):510-6. PubMed ID: 7910728
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of the proliferation-related antigen Ki-67 in oligodendrogliomas.
Kros JM; Hop WC; Godschalk JJ; Krishnadath KK
Cancer; 1996 Sep; 78(5):1107-13. PubMed ID: 8780550
[TBL] [Abstract][Full Text] [Related]
4. Proliferating cell nuclear antigen immunostaining in breast cancer and its relation to prognosis.
Narita T; Funahashi H; Satoh Y; Takagi H
Jpn J Clin Oncol; 1993 Feb; 23(1):20-5. PubMed ID: 8096256
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical investigation of p53 and EGFR expression of oligodendrogliomas.
Broholm H; Bols B; Heegaard S; Braendstrup O
Clin Neuropathol; 1999; 18(4):176-80. PubMed ID: 10442459
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of cell proliferation, epidermal growth factor receptor, and bcl-2 immunoexpression as prognostic factors for patients with World Health Organization grade 2 oligodendroglioma.
Reis-Filho JS; Faoro LN; Carrilho C; Bleggi-Torres LF; Schmitt FC
Cancer; 2000 Feb; 88(4):862-9. PubMed ID: 10679656
[TBL] [Abstract][Full Text] [Related]
7. Prognostic values of proliferating cell nuclear antigen (PCNA) and Ki-67 for radiotherapy of oesophageal squamous cell carcinomas.
Okuno Y; Nishimura Y; Kashu I; Ono K; Hiraoka M
Br J Cancer; 1999 May; 80(3-4):387-95. PubMed ID: 10408843
[TBL] [Abstract][Full Text] [Related]
8. Differences in cell proliferation and prognostic significance of proliferating cell nuclear antigen and Ki-67 antigen immunoreactivity in in situ and invasive carcinomas of the extrahepatic biliary tract.
Lee CS
Cancer; 1996 Nov; 78(9):1881-7. PubMed ID: 8909306
[TBL] [Abstract][Full Text] [Related]
9. Expression of proliferating cell nuclear antigen (PCNA) and Ki-67 in soft tissue sarcoma. Is prognostic significance histotype-specific?
Choong PF; Akerman M; Willén H; Andersson C; Gustafson P; Alvegård T; Rydholm A
APMIS; 1995 Nov; 103(11):797-805. PubMed ID: 8546844
[TBL] [Abstract][Full Text] [Related]
10. Clinicopathologic features and prognosis of resected hepatocellular carcinomas of varied sizes with special reference to proliferating cell nuclear antigen.
Suehiro T; Matsumata T; Itasaka H; Yamamoto K; Kawahara N; Sugimachi K
Cancer; 1995 Aug; 76(3):399-405. PubMed ID: 8625120
[TBL] [Abstract][Full Text] [Related]
11. Clinicopathologic study of forty-four histologically pure supratentorial oligodendrogliomas.
Prayson RA; Mohan DS; Song P; Suh JH
Ann Diagn Pathol; 2000 Aug; 4(4):218-27. PubMed ID: 10982299
[TBL] [Abstract][Full Text] [Related]
12. [Immunohistochemical investigation of proliferating cell nuclear antigen in bladder cancer].
Sumiyoshi Y; Inoue Y; Akiyama M
Nihon Hinyokika Gakkai Zasshi; 1993 Sep; 84(9):1643-8. PubMed ID: 8105131
[TBL] [Abstract][Full Text] [Related]
13. Correlations of Ki-67 and PCNA to DNA ploidy, S-phase fraction and survival in uveal melanoma.
Karlsson M; Boeryd B; Carstensen J; Frånlund B; Gustafsson B; Kågedal B; Sun XF; Wingren S
Eur J Cancer; 1996 Feb; 32A(2):357-62. PubMed ID: 8664054
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical markers for prognosis of oligodendroglial neoplasms.
Korshunov A; Golanov A; Sycheva R
J Neurooncol; 2002 Jul; 58(3):237-53. PubMed ID: 12187958
[TBL] [Abstract][Full Text] [Related]
15. Cellular proliferation in prostatic adenocarcinoma as assessed by bromodeoxyuridine uptake and Ki-67 and PCNA expression.
Cher ML; Chew K; Rosenau W; Carroll PR
Prostate; 1995 Feb; 26(2):87-93. PubMed ID: 7855002
[TBL] [Abstract][Full Text] [Related]
16. Prognostic and survival-related factors in patients with well-differentiated oligodendrogliomas.
Maiuri F; Del Basso De Caro ML; Iaconetta G; Peca C; Esposito M; de Divitiis E
Zentralbl Neurochir; 2006 Nov; 67(4):204-9. PubMed ID: 17106834
[TBL] [Abstract][Full Text] [Related]
17. PCNA/cyclin expression in transitional cell carcinomas of the human bladder: its correlation with Ki-67 and epidermal growth factor receptor immunostainings.
Serio G
Pathologica; 1994 Apr; 86(2):161-6. PubMed ID: 7936759
[TBL] [Abstract][Full Text] [Related]
18. Role of apoptosis in the prognosis of oligodendrogliomas.
Schiffer D; Dutto A; Cavalla P; Chiò A; Migheli A; Piva R
Neurochem Int; 1997 Aug; 31(2):245-50. PubMed ID: 9220457
[TBL] [Abstract][Full Text] [Related]
19. Correlation of growth fraction by Ki-67 and proliferating cell nuclear antigen (PCNA) immunohistochemistry with histopathological parameters and prognosis in primary breast carcinomas.
Haerslev T; Jacobsen GK; Zedeler K
Breast Cancer Res Treat; 1996; 37(2):101-13. PubMed ID: 8750578
[TBL] [Abstract][Full Text] [Related]
20. Immunostaining for proliferating cell nuclear antigen: its role in determination of proliferation in routinely processed human brain tumor specimens.
Khoshyomn S; Maier H; Morimura T; Kitz K; Budka H
Acta Neuropathol; 1993; 86(6):582-9. PubMed ID: 7906072
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
